Throughout the year, Chinese scientists have been working on the creation and testing of a new class of drugs aimed at treating a new coronavirus infection.. These drugs are called "

In order to identify antibodies that can neutralize the virus, scientists at Tsinghua University examine blood samples from people who have had COVID-19, and then determine the antibodies that are most effective against this virus.. As a result, a cocktail of antibodies was able to reduce the risk of developing a severe course of the disease and death by almost 78%..

“In the course of our work, we managed to modify and extend the half-life of the mutated parts of the virus. The protective period in the body after the introduction of a single dose of the new drug was 9-12 months,” said Zhang Linqi, professor at the Tsinghua University School of Medicine..

About 800 Chinese volunteers have already received a healing cocktail. Three clinical trials helped confirm the safety and efficacy of an emergency drug. Antibodies from the cocktail were able to destroy not only the usual parts of the virus, but also mutated.

At the same time, scientists from Peking University conducted a study in which a class of superantibodies was isolated. In total, the study required screening of about 8,000 sample variants..

“Sufficiently high efficiency of superantbodies against viral proteins allows the use of these antibodies in smaller quantities, which not only prolongs their duration, but also reduces the cost of the drug,” says Professor Xie Xiaoliang, Peking University..

medical-heal. en.